AGC Biologics Secures Multi-Year Yokohama Manufacturing Contract
Kuala lumpur: AGC Biologics announced that ahead of the official opening of its Yokohama site, an international biopharmaceutical company has secured half of the facility’s mammalian manufacturing capacity through a multi-year commercial contract expe…